Recent Finacing
Recent Raise
NovaGo Therapeutics develops human antibody therapeutics targeting Nogo-A to promote regeneration after stroke and other central nervous system injuries, partnering with Neurimmune and spun out from University of Zurich.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
See the team members at NovaGo Therapeutics.
